DC371739 is a potent PCSK9 inhibitor that exhibits oral bioactivity. It effectively reduces the mRNA expression of both PCSK9 and ANGPTL3, while simultaneously increasing the protein expression of LDLR. This compound holds promise for research applications related to hyperlipidemia and the modulation of lipid metabolism.
DC371739 is a potent PCSK9 inhibitor that exhibits oral bioactivity. It effectively reduces the mRNA expression of both PCSK9 and ANGPTL3, while simultaneously increasing the protein expression of LDLR. This compound holds promise for research applications related to hyperlipidemia and the modulation of lipid metabolism.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
